Article Text

Download PDFPDF
Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiation
  1. T F Greten1,
  2. M P Manns1,
  3. I Reinisch2,
  4. P Kaatsch2
  1. 1Department of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule Hannover, Germany
  2. 2German Childhood Cancer Registry, Institute for Medical Biometrics, Epidemiology and Informatics, University of Mainz, Germany
  1. Correspondence to:
    Dr T F Greten
    Department of Gastroenterology, Hepatology, and Endocrinology, Medizinische Hochschule Hannover, Carl-Neuberg Str 1, 30625 Hannover, Germany; greten.timmh-hannover.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Hepatocellular carcinoma (HCC) is one of the world’s most common malignancies and accounts for more than 90% of all primary liver cancers. A number of different risk factors have been identified for the development of HCC.1 Hepatitis B carrier state, environmental toxins, chronic hepatitis C virus infection, hereditary haemochromatosis, and liver cirrhosis of almost any cause are well known risk factors for HCC. In addition, environmental toxins such as aflatoxins and contaminated drinking water may contribute to the pathogenesis of HCC, especially in Asia and underdeveloped countries. Finally, a number of HCC cases have occurred after the use of thorotrast for diagnostic procedures, and survivors of the atomic bomb of Hiroshima were also at higher risk …

View Full Text

Footnotes

  • Conflict of interest: None declared.